For Covid-19 related information, please refer to the Ministry of Health and Family Welfare Website
Dr. Rayaz Ahmed


MBBS, MD, DM (HEMATOLOGY)

Senior Consultant, Department of Hemato-Oncology & Bone Marrow Transplant

Rajiv Gandhi Cancer Institute, Sector - 5, Rohini, Delhi - 110 085

SPECIALIZED AREAS

Matched Sibling donor Stem cell transplant
Matched Unrelated Donor Stem cell Transplant
Matched Unrelated Donor Stem cell Transplant
Haematological disorders including Aplastic Anemia and Thalassemia Major

EDUCATIONAL BACKGROUND

D.M. (Hematology) - Christian Medical College & Hospital, Vellore 631004, TN, INDIA, 2010
M.D. - Shivaji University Kolhapur, Maharashtra, INDIA, 2003
M.B.B.S. - Pt.Ravi Shanker university, Raipur, C.G. INDIA, 1999

EXPERIENCES

Worked as associate professor in Department of Hematology CMC Vellore, from 2010-2013
Performed 300+ Stem Cell Transplants at Rajiv Gandhi Cancer Institute & Research Centre
Worked as Principle-Investigator in many Medical Oncology/Hematology Trials since 2010

MEMBERSHIPS

Member of American Society of Hematology
Member of International Myeloma Working Group.

ABOUT

Dr. Rayaz Ahmed has been trained in CMC Vellore and has special interest in Stem cell transplant/ Bone Marrow Transplant. He is having more than 10 years of experience in Stem cell Transplant including Allogeneic, Autologous, MUD (Matched Unrelated donor) and Haplo Stem Cell Transplant.
He received training & fellowship in Bone Marrow Transplantation from CMC Vellore. He was Ex Associate professor at CMC Vellore.

PROFESSIONAL JOURNEY

ACHIEVEMENTS
Credited with the start of multiple pioneer works in field of Haemato-oncology and organized much training in this field at global level.
AWARDS
University Gold Medal in MD Pathology 2003, Shivaji University, Kolhapur, Maharashtra.
PUBLICATIONS
Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP. Ahmed R, Devasia AJ, Viswabandya A, Lakshmi KM, Abraham A, Karl S, Mathai J, Jacob PM, Abraham D, Srivastava A, Mathews V, George B. Ann Hematol. 2016 Jul 2.
Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study. Kapoor J, Agrawal N, Ahmed R, Sharma SK, Gupta A, Bhurani D. Mediterr J Hematol Infect Dis. 2015 Feb 20;7(1)
V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia. Arora N, Nair S, Pai R, Nair S, Ahmed R, Abraham A, Viswabandya A, George B, Balasubramanian P, Srivastava A, Mathews V. Indian J Pathol Microbiol. 2015 Jan-Mar;58(1):62-5.
The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia--a retrospective analysis from three Indian centers. George B, Mathews V, Lakshmi KM, Melinkeri S, Sharma A, Viswabandya A, Sharma S, Das S, Ahmed R, Abraham A, Nair V, Apte S, Chandy M, Srivastava A. Clin Transplant. 2013 Nov-Dec;27(6):923-9.
Two novel missense mutations in iron transport protein transferrin causing hypochromic microcytic anaemia and haemosiderosis: molecular characterization and structural implications. Athiyarath R, Arora N, Fuster F, Schwarzenbacher R, Ahmed R, George B, Chandy M, Srivastava A, Rojas AM, Sanchez M, Edison ES. Br J Haematol. 2013 Nov;163(3):404-7
Outcome of treatment with a low cost protocol in adults with T cell acute lymphoblastic leukemia in a tertiary care center in India. Abraham A, George B, Ahmed R, Viswabandya A, Mathews V, Lakshmi KM, Srivastava VM, Chandy M, Srivastava A. Leuk Lymphoma. 2014 Apr;55(4):947-9
Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts. Mathews V, George B, Viswabandya A, Abraham A, Ahmed R, Ganapule A, Sindhuvi E, Lakshmi KM, Srivastava A. PLoS One. 2013 Apr 26;8(4)
Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis. Jain PP, Parihar M, Ahmed R, Abraham A, Vishwabandya A, George B, Mathews V, Srivastava A, Srivastava VM. Indian J Pathol Microbiol. 2012 Jul-Sep;55(3):347-51
Molecular basis of Wiskott-Aldrich syndrome in patients from India. David S, Jayandharan GR, Abraham A, Jacob RR, Devi GS, Patkar N, Shaji RV, Nair SC, Viswabandya A, Ahmed R, George B, Mathews V, Chandy M, Srivastava A. Eur J Haematol. 2012 Oct;89(4):356-60
Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia. Varatharajan S, Abraham A, Zhang W, Shaji RV, Ahmed R, Abraham A, George B, Srivastava A, Chandy M, Mathews V, Balasubramanian P. Eur J Clin Pharmacol. 2012 Dec;68(12):1577-86
Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country. Patkar N, Alex AA, B B, Ahmed R, Abraham A, George B, Vishwabandya A, Srivastava A, Mathews V. Cytometry B Clin Cytom. 2012 Jul;82(4):252-8.
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy. Chendamarai E, Balasubramanian P, George B, Viswabandya A, Abraham A, Ahmed R, Alex AA, Ganesan S, Lakshmi KM, Sitaram U, Nair SC, Chandy M, Janet NB, Srivastava VM, Srivastava A, Mathews V. Blood. 2012 Apr 12;119(15):3413-9
Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia. Abraham A, Varatharajan S, Abbas S, Zhang W, Shaji RV, Ahmed R, Abraham A, George B, Srivastava A, Chandy M, Mathews V, Balasubramanian P. Pharmacogenomics. 2012 Feb;13(3):269-82
Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India. Patkar N, Nair S, Alex AA, Parihar M, Manipadam MT, Arora N, Ahmed R, Abraham A, George B, Viswabandya A, Srivastava V, Srivastava A, Mathews V. Leuk Lymphoma. 2012 Apr;53(4):609-15.
Gonadoblastoma with unusual mixed germ cell overgrowth--a case report. Tambekar RG, Ahmed R, Deshpande NM, Zawar MP. Indian J Pathol Microbiol. 2005 Jul;48(3):381-3.
Pediatric myelodysplastic syndromes - a developing countries perspective B. George, V. Mathews, A. Abraham, R. Ahmed, V. Srivastava, A. Srivastava Leukemia Research May 2011 Volume 35, Supplement 1, Page S34
Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India. Patkar N1, Nair S, Alex AA, Parihar M, Manipadam MT, Arora N, Ahmed R, Abraham A, George B, Viswabandya A, Srivastava V, Srivastava A, Mathews V. Leuk Lymphoma. 2012 Apr;53(4):609-15
Register Now